✦ LIBER ✦

Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation

✍ Scribed by Y. Ueda; Y. Takada; H. Marusawa; H. Haga; T. Sato; Y. Tanaka; H. Egawa; S. Uemoto; T. Chiba

Book ID: 108886357
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 165 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2009.01207.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histologic recurrence of chronic hepatit

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation

✍ Mitchell L. Shiffman; R. Todd Stravitz; Melissa J. Contos; A. Scott Mills; Richa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We

Is recurrence of hepatitis C worse after

Is recurrence of hepatitis C worse after living donor or deceased donor liver transplantation?

✍ Robert S. Brown Jr. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

Effect of maintenance therapy with low-d

Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation

✍ Y. Ueda; H. Marusawa; T. Kaido; Y. Ogura; F. Oike; A. Mori; K. Ogawa; A. Yoshiza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Effects of double-filtration plasmaphere

Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation

✍ Yasutsugu Takada; Takashi Ito; Yoshihide Ueda; Hironori Haga; Hiroto Egawa; Koic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmaco

Immunohistochemical staining of liver gr

Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation

✍ Hiroshi Sadamori; Takahito Yagi; Hiromi Iwagaki; Hiroaki Matsuda; Susumu Shinour 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

The difference in the fibrosis progressi

The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age

✍ Nazia Selzner; Nigel Girgrah; Les Lilly; Maha Guindi; Markus Selzner; George The 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

Hepatitis C recurs universally after liver transplantation (LT). Whether its progression differs after live donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) is still debated. We retrospectively analyzed 201 consecutive LTs performed at our institution for hepatitis